BMO Capital Initiates Coverage On Globus Medical with Outperform Rating, Announces Price Target of $94
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsInitiationPrice Target
BMO Capital initiates coverage on Globus Medical (NYSE:GMED) with a Outperform rating and announces Price Target of $94.
BMO Capital initiates coverage on Globus Medical (NYSE:GMED) with a Outperform rating and announces Price Target of $94.